| Literature DB >> 31881683 |
Guillermo Lasarte-Aragonés1, Alejandro Álvarez-Lueje2, Ricardo Salazar3, Carla Toledo-Neira3.
Abstract
In the present work, the effectiveness of switchable hydrophobicity solvents (SHSs) as extraction solvent (N,N-Dimethylcyclohexylamine (DMCA), N,N-Diethylethanamine (TEA), and N,N-Benzyldimethylamine (DMBA)) for a variety of emerging pollutants was evaluated. Different pharmaceutical products (nonsteroidal anti-inflammatory drugs (NSAIDs), hormones, and triclosan) were selected as target analytes, covering a range of hydrophobicity (LogP) of 3.1 to 5.2. The optimized procedure was used for the determination of the target pharmaceutical analytes in wastewater samples as model analytical problem. Absolute extraction recoveries were in the range of 51% to 103%. The presented method permits the determination of the target analytes at the low ng mL-1 level, ranging from 0.8 to 5.9 (except for Triclosan, 106 ng mL-1) with good precision (relative standard deviation lower than 6%) using high-pressure liquid chromatography (HPLC) combined with ultraviolet (DAD) and fluorescence (FLR) detection. The microextraction alternative resulted in a fast, simple, and green method for a wide variety of analytes in environmental water sample. The results suggest that this type of solvent turns out to be a great alternative for the determination of different analytes in relatively complex water samples.Entities:
Keywords: emerging contaminants; high-performance liquid chromatography; homogeneous liquid-liquid microextraction; partition coefficient; switchable hydrophobicity solvents
Mesh:
Substances:
Year: 2019 PMID: 31881683 PMCID: PMC6982722 DOI: 10.3390/molecules25010086
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Extraction recovery (%) for the selected target analytes for the two suitable switchable hydrophilicity solvents (SHS) candidates.
Figure 2Effect of the extractant phase volume (50:50 SHS:Water) (a); sample volume (b) and NaOH as phase separation (c) trigger on the extraction recovery for a standard solution containing the model analytes at 500 ng L−1.
Analytical features for the extraction of emerging contaminants by SHS-homogeneous liquid–liquid microextraction (HLLME).
| Analyte | Linear Range | R 1 | LOD 2 | LOQ 3 | LogP a | AER 4 | Precision | EF 6 |
|---|---|---|---|---|---|---|---|---|
| Ketoprofen | 100–20,000 | 0.997 | 1.9 | 6.4 | 3.1 | 51 | 3.2 | 9 |
| Naproxen | 100–20,000 | 0.999 | 0.8 | 2.7 | 3.2 | 56 | 4.3 | 10 |
| Diclofenac | 300–20,000 | 0.998 | 5.3 | 17.6 | 4.5 | 99 | 4.1 | 18 |
| Ibuprofen | 150–20,000 | 0.999 | 2.3 | 7.6 | 4.0 | 90 | 5.3 | 18 |
| Mefenamic Acid | 300–20,000 | 0.999 | 5.9 | 19.6 | 5.2 | 98 | 3.4 | 18 |
| Triclosan | 6400–20,000 | 0.996 | 106 | 356 | 5 | 103 | 1.8 | 18 |
| E2 | 250–50,000 | 0.999 | 3.7 | 12.2 | 4 | 85 | 3.6 | 15 |
| EE | 250–50,000 | 0.994 | 4.5 | 14.9 | 3.7 | 82 | 6.0 | 15 |
1 Regresion coefficient; 2 Limit of Detection; 3 Limit of Quantification; 4 Absolute Extraction Recovery; 5 Relative Standard Deviation; 6 Enrichment Factor; a data provided by ChemIDplus (SRC Inc.).
Figure 3Effect of the target analyte hydrophobicity (LogP) in the absolute extraction recovery (expressed as %) in aqueous samples for N,N-Dimethylcyclohexylamine (DMCA) as extractant SHS.
Relative recovery study by SHS-HLLME for the extraction of emerging contaminants in wastewater.
| Analyte | Spiked | Found | Recovery |
|---|---|---|---|
| Ketoprofen | 30 | 17 ± 1 | 57 ± 5 |
| Naproxen | 30 | 15 ± 1 | 50 ± 7 |
| Diclofenac | 360 | 350 ± 13 | 97 ± 4 |
| Ibuprofen | 30 | 27 ± 2 | 91 ± 7 |
| Mefenamic acid | 360 | 359 ± 15 | 99 ± 4 |
| EE | 30 | 26 ± 2 | 85± 7 |
| E2 | 30 | 27 ± 1 | 86± 4 |
| Triclosan | 360 | 360 ± 18 | 100 ± 5 |
1 SD Standard Deviation.
Comparison of the proposed extraction procedure with other published methods for the pharmaceutical compounds from water samples.
| Extraction Technique | Analytes | Sample Volume | Extractant Amount | Inst. Technique | LOD 1 | Proc. Time | Notes | Ref. |
|---|---|---|---|---|---|---|---|---|
| FSPE 2 | Steroid Hormones | 10 | Fabric piece | UHPLC-MS/MS | 0.001–0.264 | 45 | Solvent wash fabric reuse | [ |
| BAµE 3 | 25 | 8.1 mg | HPLC-DAD | 0.01–0.1 | Hours (16.5) | Long procedure | [ | |
| DLLME | 4.5 | 250 µL | GC-MS | 0.011–0.082 | 3 | Derivatization required | [ | |
| DLLME | 7.5 | 110 µL | MEKC 4–MS | 0.04–1.1 | 7 | [ | ||
| DLLME-SFO 5 | 5 | 10 µL | UPLC-UV | 0.8–2.7 | n/a 6 | [ | ||
| SHS-HLLME | 8 | 375 µL | HPLC-DAD-FLR | 3.7–4.5 | 2.3 | Present method | ||
| HF-LPME | NSAIDs | 50 | 20 cm Fiber | HPLC-MS | 7.1–89.3 | Hours (n/a) | Long sample preparation | [ |
| µLPME | 0.005 | 5.0 µL | HPLC-UV | 70–300 | 5 | Microfluidic device | [ | |
| DLLME | 5 | 200 µL | HPLC-DAD-MS | 0.65–1.3 | 15 | [ | ||
| DLLME | 5 | 90 µL | HPLC-UV | 17–95 | n/d | [ | ||
| SHS-HLLME | 8 | 375 µL | HPLC-DAD-FLR | 0.8–5.9 | 2.3 | Present method |
1 Limit of Detection; 2 Fabric Phase Sorptive Extraction; 3 Bar Adsorptive microextraction; 4 Micellar Electrokinetic Chromatography; 5 Single Floating Organic drop; 6 not available/disclosed.